Studies of efficacy and safety of simultaneous administration of febuxostat and inosine for patients with genetic anemia, and changes of blood and urine purine compounds
Not Applicable
- Conditions
- genetic anemia
- Registration Number
- JPRN-UMIN000024750
- Lead Sponsor
- Tsukuba International Clinical Pharmacology Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
1.Subjects taking azathioprine or mercaptopurine 2.Subject who has or had renal function disorder. 3.Subject with a history of gout, hyperuricemia or urolithiasis. 4.Subject who has or had hypersensitivity, idiosyncracy (allergy) to drug. 5.Subjects to whom either transfusion or surgical treatment such as splenectomy was made within 3 months before the initiation of the drug therapy. 6.Subject who was judged not to be appropriate by the principal investigator or sub investigators by other reasons.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method